Immix Biopharma (IMMX) Equity Average (2021 - 2026)

Quarterly results put Equity Average at $89.1 million for Q1 2026, up 679.87% from a year ago — trailing twelve months through Mar 2026 was $89.1 million (up 679.87% YoY), and the annual figure for FY2025 was $53.5 million, up 263.43%.

Immix Biopharma has reported Equity Average over the past 6 years, most recently at $89.1 million for Q1 2026.

  • Equity Average reached $89.1 million in Q1 2026 per IMMX's latest filing, up from $51.0 million in the prior quarter.
  • Across five years, Equity Average topped out at $89.1 million in Q1 2026 and bottomed at $6.5 million in Q3 2025.
  • Median Equity Average over the past 5 years was $17.4 million (2022), compared with a mean of $22.2 million.
  • The largest annual shift saw Equity Average plummeted 72.35% in 2025 before it surged 679.87% in 2026.
  • Over 5 years, Equity Average stood at $15.0 million in 2022, then increased by 19.87% to $17.9 million in 2023, then dropped by 14.09% to $15.4 million in 2024, then soared by 231.35% to $51.0 million in 2025, then skyrocketed by 74.56% to $89.1 million in 2026.
  • Business Quant data shows Equity Average for IMMX at $89.1 million in Q1 2026, $51.0 million in Q4 2025, and $6.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 3.76 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 19.01 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 31.34 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 932.28 Mn
10 Immix Biopharma 476.17 Mn 476.17 Mn - 89.08 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 89.08 Mn
Dec 31, 2025 51.03 Mn
Sep 30, 2025 6.46 Mn
Jun 30, 2025 7.12 Mn
Mar 31, 2025 11.42 Mn
Dec 31, 2024 15.40 Mn
Sep 30, 2024 20.72 Mn
Jun 30, 2024 25.76 Mn
Mar 31, 2024 21.92 Mn
Dec 31, 2023 17.93 Mn
Sep 30, 2023 16.41 Mn
Jun 30, 2023 12.45 Mn
Mar 31, 2023 12.45 Mn
Dec 31, 2022 14.95 Mn
Sep 30, 2022 17.43 Mn
Jun 30, 2022 18.88 Mn
Mar 31, 2022 18.82 Mn
Dec 31, 2021 5.90 Mn
Sep 30, 2021 -6.02 Mn
Jun 30, 2021 -5.78 Mn
Mar 31, 2021 -5.22 Mn